Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus

Oct.26.2022
Advocates Seek Ban on Menthol Cigarettes and Flavored e-Cigarettes in Columbus
Advocates call for ban on flavored tobacco products in Columbus stores to address marketing targeting vulnerable communities.

Health advocates are urging the Columbus City Council to ban the sale of menthol cigarettes and flavored electronic cigarettes in stores throughout the city.


Amanda Turner, the Executive Director of Tobacco 21, stated that the city council has not yet proposed any legislation, but the proposal is currently being drafted. Turner explained that this issue first arose approximately 18 months ago during a conversation with the Columbus Department of Public Health.


Dr. Phillip Gardner, a public health expert, has stated that 85 cities in the United States have already banned the sale of menthol cigarettes and flavored e-cigarettes, with an additional 300 cities recently banning the sale of flavored e-cigarettes. Gardner, who is co-chair of the African American Tobacco Control Leadership Council, also noted that Canada has a nationwide ban on the sale of menthol cigarettes.


Gardner and Turner stated that prohibiting the sale of these products in the city will begin to reverse the effects of decades of marketing aimed specifically at black people, other people of color, women, LGBTQ individuals, and other marginalized groups. Gardner said that the industry profits by using "disproportionate marketing and predatory plunder" to exploit vulnerable communities and make a profit.


According to him, tobacco marketers have discovered that promoting menthol cigarettes to black celebrities and athletes, even lowering their costs in communities with African Americans. Currently, 85% of black smokers use menthol cigarettes, while the same figure for white smokers is 30%. "In the early 1950s, only 5% of African Americans smoked menthol cigarettes. By 1968, this percentage had almost tripled to 14%. By 1976, it had tripled again to 42%," Gardner said.


He stated that despite critics suggesting that such a ban would only create an illegal market or push shoppers to other jurisdictions, the data indicates that this has not been the case in these areas. Turner further explained that the data shows that removing more addictive tobacco from the equation would aid individuals in quitting smoking.


Many individuals may switch products, but research indicates that if you are using menthol cigarettes and wish to quit smoking and switch to regular cigarettes, your chances of successfully quitting are higher because menthol is a flavoring. It is a cooling agent that can suppress coughing, Turner explained.


Gardner stated that this is "outrageous" because adding menthol makes people more susceptible to nicotine addiction and more difficult to quit. "Menthol is defined as an anesthetic that actually covers up the harsh taste of tobacco smoke. It has a numbing and cooling effect and allows for deeper inhalation. The deeper you inhale, the more toxins and nicotine you ingest," Gardner said. "The more nicotine and toxins you ingest, the more addicted you become. Quitting becomes even harder. That's why they put it in there. It's outrageous from the start.


Gardiner stated that the FDA is currently exploring the idea of banning the use of menthol in cigarettes, but the process would take too long. "The FDA is considering getting rid of menthol, but unfortunately, due to the FDA's delay, it is important for communities like Columbus to take action themselves. The FDA will need several years to accomplish this," he said.


Turner and Gardner stated that the ban would not prohibit products within the city, but only the sale of them. Therefore, individuals would not face trouble for purchasing and bringing them in from elsewhere. "These laws are about getting retailers to stop selling them and not about individuals using personal property or pursuing a percentage," said Gardner.


Critics say the ban is unfair to smokers who enjoy menthol or use flavored e-cigarettes as an alternative to traditional cigarettes. Some argue that it discriminates against Black smokers. In response, Gardner stated that "racists are not public health doctors, they're in the tobacco industry." "Indeed, it has been the tobacco industry that has been discriminatory, that has been racist," Gardner continued. "It is not the tobacco control movement that is trying to save lives.


When asked why health officials are taking action to prevent flavored tobacco instead of flavored alcohol, Gardner explained that occasional alcohol consumption, not including binge drinking, does not kill people. However, "if you use cigarettes as expected, 50% of people will die from smoking.


Cigarettes are more deadly. In fact, tobacco-related diseases are the leading cause of death in the world, including in the United States, Ohio, and unfortunately Columbus. This is the reality. We are working hard to save lives," Gardner said.


Art Way, a drug policy consultant who works with the tobacco industry, argues that focusing on smoking cessation is a more effective way to reduce nicotine addiction. Targeted bans like these, Way contends, are similar to "patronizing, drug war-type policies that do not benefit our communities.


Statement:


This article is based on compiled third-party information and is only intended for intra-industry communication and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is solely for industry research and communication purposes.


Due to limitations in translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan or foreign-related expressions and perspectives.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italy's Guardia di Finanza announced on October 28 that officers in Latina province had seized approximately 4.3 million e-cigarettes and smoking accessories at an unauthorized warehouse in an operation involving restrictions on the possession and sale of tobacco-related products. Another 300,000 suspected counterfeit or unsafe items were confiscated during separate inspections, bringing total seizures across the operations to more than 4.6 million products. Twenty-eight people were reported to judicial authorities over suspected smuggling and counterfeiting offenses. Officials did not disclose separate vape quantities, the value of the merchandise or alleged violations associated with individual brands.
Enforcement
Oct.29
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives